Scott Shannon is a Psychiatry physician affiliated with University of Colorado Denver. OpenAlex indexes 38 publications with 1,016 citations (h-index 10); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7603 Colland Dr
Fort Collins, CO 805256929
Telephone
970-663-2686Registry record last updated 7 Mar 2023.
Clinical trials
- A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)
Sponsor: Resilient Pharmaceuticals
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Pharmaceuticals, IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SSRI57.1%Fluoxetine Hcl100%Part D<11 patientsSNRI42.9%Venlafaxine Hcl Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Resting State EEG Correlates of Suicide Ideation and Suicide Attempt
Journal of Personalized Medicine
2023 - A Holistic Self-learning Approach for Young Adult Depression and Anxiety Compared to Medication-Based Treatment-As-Usual
Community Mental Health Journal
2020 - Response to Stuyt and Hilderbrand re: “Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series” ( <i>J Altern Complement Med</i> 2020;26:349–350. DOI: 10.1089/acm.2019.0380)
The Journal of Alternative and Complementary Medicine
2020 - The Role of Psychedelic Agents in Treatment of Mood Disorders and Addictions: A Clinical Conversation with Scott Shannon, MD, and Robert Rountree, MD
Alternative and Complementary Therapies
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Virginia Borges, MD
University of Colorado Denver
Kristine Erlandson, MD
University of Colorado Denver
Kaweh Mansouri
University of Colorado Denver
Patricia Gabow, MD
University of Colorado Denver
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Raquel Gur, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”